Literature DB >> 28464746

Autodelineation of cervical cancers using multiparametric magnetic resonance imaging and machine learning.

Turid Torheim1, Eirik Malinen2,3, Knut Håkon Hole4, Kjersti Vassmo Lund4, Ulf G Indahl1, Heidi Lyng5, Knut Kvaal1, Cecilia M Futsaether1.   

Abstract

BACKGROUND: Tumour delineation is a challenging, time-consuming and complex part of radiotherapy planning. In this study, an automatic method for delineating locally advanced cervical cancers was developed using a machine learning approach.
MATERIALS AND METHODS: A method for tumour segmentation based on image voxel classification using Fisher?s Linear Discriminant Analysis (LDA) was developed. This was applied to magnetic resonance (MR) images of 78 patients with locally advanced cervical cancer. The segmentation was based on multiparametric MRI consisting of T2- weighted (T2w), T1-weighted (T1w) and dynamic contrast-enhanced (DCE) sequences, and included intensity and spatial information from the images. The model was trained and assessed using delineations made by two radiologists.
RESULTS: Segmentation based on T2w or T1w images resulted in mean sensitivity and specificity of 94% and 52%, respectively. Including DCE-MR images improved the segmentation model?s performance significantly, giving mean sensitivity and specificity of 85?93%. Comparisons with radiologists? tumour delineations gave Dice similarity coefficients of up to 0.44.
CONCLUSION: Voxel classification using a machine learning approach is a flexible and fully automatic method for tumour delineation. Combining all relevant MR image series resulted in high sensitivity and specificity. Moreover, the presented method can be extended to include additional imaging modalities.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28464746     DOI: 10.1080/0284186X.2017.1285499

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  6 in total

1.  Computer-based automatic classification of trabecular bone pattern can assist radiographic bone quality assessment at dental implant site.

Authors:  Laura Ferreira Pinheiro Nicolielo; Jeroen Van Dessel; G Harry van Lenthe; Ivo Lambrichts; Reinhilde Jacobs
Journal:  Br J Radiol       Date:  2018-09-17       Impact factor: 3.039

2.  RefineNet-based 2D and 3D automatic segmentations for clinical target volume and organs at risks for patients with cervical cancer in postoperative radiotherapy.

Authors:  Chengjian Xiao; Juebin Jin; Jinling Yi; Ce Han; Yongqiang Zhou; Yao Ai; Congying Xie; Xiance Jin
Journal:  J Appl Clin Med Phys       Date:  2022-05-09       Impact factor: 2.243

3.  Fully Automatic Whole-Volume Tumor Segmentation in Cervical Cancer.

Authors:  Erlend Hodneland; Satheshkumar Kaliyugarasan; Kari Strøno Wagner-Larsen; Njål Lura; Erling Andersen; Hauke Bartsch; Noeska Smit; Mari Kyllesø Halle; Camilla Krakstad; Alexander Selvikvåg Lundervold; Ingfrid Salvesen Haldorsen
Journal:  Cancers (Basel)       Date:  2022-05-11       Impact factor: 6.575

4.  Semi-automatic tumor segmentation of rectal cancer based on functional magnetic resonance imaging.

Authors:  Franziska Knuth; Aurora R Groendahl; René M Winter; Turid Torheim; Anne Negård; Stein Harald Holmedal; Kine Mari Bakke; Sebastian Meltzer; Cecilia M Futsæther; Kathrine R Redalen
Journal:  Phys Imaging Radiat Oncol       Date:  2022-05-11

5.  Deep learning for fully automated tumor segmentation and extraction of magnetic resonance radiomics features in cervical cancer.

Authors:  Yu-Chun Lin; Chia-Hung Lin; Hsin-Ying Lu; Hsin-Ju Chiang; Ho-Kai Wang; Yu-Ting Huang; Shu-Hang Ng; Ji-Hong Hong; Tzu-Chen Yen; Chyong-Huey Lai; Gigin Lin
Journal:  Eur Radiol       Date:  2019-11-11       Impact factor: 5.315

Review 6.  Realizing the potential of magnetic resonance image guided radiotherapy in gynaecological and rectal cancer.

Authors:  Ingrid M White; Erica Scurr; Andreas Wetscherek; Gina Brown; Aslam Sohaib; Simeon Nill; Uwe Oelfke; David Dearnaley; Susan Lalondrelle; Shreerang Bhide
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.